FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls (Q43941932)

28 November 2017

0 references

FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls (English)

1 reference

28 November 2017

6

1 reference

28 November 2017

8

1 reference

28 November 2017

Li-Xin Qiu

1

1 reference

28 November 2017

Jian Shi

2

1 reference

28 November 2017

Hui Yuan

3

1 reference

28 November 2017

Xin Jiang

4

1 reference

28 November 2017

Kai Xue

5

1 reference

28 November 2017

Jin Li

7

1 reference

28 November 2017

19 February 2009

1 reference

28 November 2017

1 reference

28 November 2017

125

1 reference

28 November 2017

4

1 reference

28 November 2017

431-435

1 reference

https://scigraph.springernature.com/pub.10.1007/s00439-009-0639-4

28 November 2017

0 references

cites work

Bias in meta-analysis detected by a simple, graphical test

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00439-009-0639-4

Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

21 January 2018

1 reference

12 December 2020

Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer

1 reference

12 December 2020

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia

1 reference

12 December 2020

Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.

1 reference

12 December 2020

Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.

1 reference

12 December 2020

Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

1 reference

12 December 2020

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

12 December 2020

Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene

1 reference

12 December 2020

Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.

1 reference

12 December 2020

Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis

1 reference

12 December 2020

Functional variants in cell death pathway genes and risk of pancreatic cancer.

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk

1 reference

12 December 2020

FAS −1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer

1 reference

12 December 2020

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer

1 reference

12 December 2020

Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma

1 reference

12 December 2020

Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis

1 reference

12 December 2020

Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma

1 reference

12 December 2020

10.1007/S00439-009-0639-4

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference